Docosatetraenoic acid (DTA) is a very long chain omega-6 fatty acid with 22 carbons and 4 double bonds (22:4n6).
It is synthesized by adding 2 carbons atoms to the backbone of arachidonic acid using the elongase enzyme. It is sometimes referred to by its common name adrenic acid and is one of the most abundant fatty acids in the early human brain and the adrenal gland. DTA has not been well studied, though it has recently been shown to have important physiologic functions. It is now believed to be a pro-resolving mediator in inflammation by blocking neutrophilic metabolites and dampening the inflammation response. For example, in osteoarthritis DTA enhances phagocytosis by macrophages which clears products of cartilage breakdown in the joint space. Supplementation of DTA is being studied as a promising intervention in osteoarthritis to dampen inflammation and prevent structural damage.
Much like AA (its precursor) DTA/adrenic acid is an important component of infant development. DTA is the third most abundant PUFA in the brain and it is necessary for neural tissue development. DTA is also prevalent in the vasculature. It is metabolized to biologically active prostaglandins and epoxyeicosatrienoic acids (EETs) which activate smooth muscle channels causing relaxation and vasodilation. There is some literature to also support DTA/adrenic acid’s role in inducing oxidative stress and cell death through modulating superoxide dismutase enzymes.
References:
- Kopf PG, Zhang DX, Gauthier KM, et al. Adrenic acid metabolites as endogenous endothelium-derived and zona glomerulosa-derived hyperpolarizing factors. Hypertension. 2010;55(2):547-554.
- Brouwers H, Jonasdottir H, Kwekkeboom J, et al. Adrenic acid as a novel anti-inflammatory player in osteoarthritis. Osteoarthritis and Cartilage. 2018;26:S126.
- Hadley KB, Ryan AS, Forsyth S, Gautier S, Salem N. The essentiality of arachidonic acid in infant development. Nutrients. 2016;8(4):216.
- Yi XY, Gauthier KM, Cui L, Nithipatikom K, Falck JR, Campbell WB. Metabolism of adrenic acid to vasodilatory 1alpha,1beta-dihomo-epoxyeicosatrienoic acids by bovine coronary arteries. American journal of physiology Heart and circulatory physiology. 2007;292(5):H2265-2274.
- Nababan SHH, Nishiumi S, Kawano Y, Kobayashi T, Yoshida M, Azuma T. Adrenic acid as an inflammation enhancer in non-alcoholic fatty liver disease. Archives of biochemistry and biophysics. 2017;623:64-75.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.